New immunotherapy approach shows promise for minimizing spinal cord injury damage

WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune cells.

Psychedelics Companies Investors Should Get To Know

In this latest Trade to Black podcast, Matthew “Whiz” Buckley, psychedelic investor and No Fallen Heroes Founder joins host Shadd Dales and millennial entrepreneur Andrew

July 17, 2023

Updated: Merck commits up to $610M to buy out preclinical biotech and its neurodegenerative disease work

Merck is snapping up a private biotech focused on genetically defined neurodegenerative disorders and rare diseases, promising to pay $610 million if everything works out.

November 22, 2023

Soaring MSOs Lead Cannabis Stocks Higher in January

As we described in a previous article, the Global Cannabis Stock Index extended the bounce from November after the huge October loss, rallying 8.1% in December. That index was

February 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.